APA (7th ed.) Citation
(2026). MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. Neuro-Oncology Advances.
Chicago Style (17th ed.) Citation
"MEK Inhibitors for Neurofibromatosis Type 1-associated Central and Peripheral Nervous System Tumors." Neuro-Oncology Advances 2026.
MLA (9th ed.) Citation
"MEK Inhibitors for Neurofibromatosis Type 1-associated Central and Peripheral Nervous System Tumors." Neuro-Oncology Advances, 2026.
Warning: These citations may not always be 100% accurate.